Andrew Spillane, MBBS, MD, FRACS

Surgeon
Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia, Australia

Presentation(s):

• 63: An Externally Validated Online Tool To Calculate Personalized Probabilities Of Recurrence-Free And Overall-Survival In Stage II Melanoma Patients.

  Thursday, March 21, 2024
  2:27pm – 2:37pm ET

• P43: Innovation in Collaborating and Funding an International Cancer Clinical Trial

  Friday, March 22, 2024
  11:07am – 11:13am ET

• 59: Surgical considerations for resecting the index lymph node after neo-adjuvant checkpoint inhibitors: lessons learned from the PRADO trial

  Friday, March 22, 2024
  2:02pm – 2:14pm ET